简体中文
|
繁體中文
|
English
Business Wire Global sites
Business Wire Global
UK/Ireland
Deutschland
France
Italy
Japan
Home
News
Events
Media Services
About Us
Contact Us
Health and Pharmaceutical Press Releases
2018-10-09 09:40
Huntsman Cancer Institute at the University of Utah Selects Mevion to Provide Compact Single-Room System for the First Proton Therapy Center in Utah
2018-10-09 09:29
Celgene Announces Phase 3 STYLE Study of OTEZLA® (apremilast) in Moderate to Severe Scalp Psoriasis Met Primary Endpoint
2018-10-08 18:43
New Study Evaluates the Ability of Masimo ORi™ to Help Clinicians Reduce Hyperoxemia in Mechanically Ventilated ICU Patients
2018-10-08 14:14
Takeda Establishes Record Date for the Extraordinary General Meeting of Shareholders
2018-10-08 10:40
Boehringer Ingelheim and Lilly present full results of Trajenta®’s CARMELINA® cardiovascular outcome trial
2018-10-08 10:35
Boehringer Ingelheim and Lilly present full results from EASE Phase III programme for empagliflozin as adjunct to insulin in type 1 diabetes
2018-10-08 10:06
PMI Releases Position Paper for COP8: Addresses Need for Harm-Reduction Strategies
2018-10-08 09:38
Inter Partner Assistance Hong Kong Ltd. Forms a Partnership With The CareVoice To Provide Fully Digital Health Journeys and Integrated Healthcare Solutions to the Hong Kong Health Insurance Market
2018-09-27 17:59
Takeda to Present Positive Data from ALUNBRIG® (brigatinib) ALTA-1L Trial Showing a Reduction in Risk of Disease Progression or Death of More Than 50 Percent Versus Crizotinib in First-Line Advanced ALK+ NSCLC
2018-09-26 16:25
Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC
2018-09-26 14:31
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
2018-09-26 09:52
PMI: Taking Bold Action for Global Change: a Conversation on Tobacco Today and Transformation for Tomorrow
2018-09-25 18:39
Emergent BioSolutions Expands Manufacturing Capability with ABEC Dual Purpose Single-Use Microbial Fermentation / Mammalian Cell Culture Systems
2018-09-25 15:42
WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines
2018-09-19 17:45
175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis
2018-09-19 16:51
Immunomic Therapeutics to Present at the 2018 China BioMed Innovation and Investment Conference
2018-09-18 13:50
HEX Concludes With $20 Million in Successful Token Sale
2018-09-18 11:49
Congenica Announces Market Access Partnership with Digital China Health to Enable Genomic Medicine in the Chinese Market
2018-09-18 09:53
Biolog-id Branches out to the United States with a New Operational Center in Atlanta
2018-09-17 15:16
Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice1
<< First
< Previous
180
181
182
183
184
185
186
187
188
189
Next >
Last >>
38695
38693
38691
38684
38678
38676
38670
38666
38648
38625
38619
38611
38607
38604
38561
38560
38542
38541
38538
38532
Business Wire Weibo
Press Releases
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2026-05-09 17:08
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company
2026-05-09 16:53
UAE Commits $49bn to Local Manufacturers
2026-05-09 16:51
Twilio’s Next Generation Platform: An Infrastructure Layer for Every Conversation in the Agentic Era
2026-05-09 16:48
Beneq Appoints Dr. Jason Harrison as Chief Executive Officer
2026-05-09 16:44
Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders